Invention Grant
- Patent Title: Epitope as a target for therapy of inflammatory autoimmune diseases and graft rejection
-
Application No.: US15529095Application Date: 2015-11-17
-
Publication No.: US10975122B2Publication Date: 2021-04-13
- Inventor: Nathan Karin , Gizi Wildbaum
- Applicant: Technion Research & Development Foundation Limited
- Applicant Address: IL Haifa
- Assignee: Technion Research & Development Foundation Limited
- Current Assignee: Technion Research & Development Foundation Limited
- Current Assignee Address: IL Haifa
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- International Application: PCT/IL2015/051107 WO 20151117
- International Announcement: WO2016/084062 WO 20160602
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C07K14/705 ; G01N33/564 ; C07K16/28 ; A61P37/00 ; A61P29/00 ; A61P37/06 ; A61K39/395 ; A61K38/17 ; A61K38/00 ; A61K39/00 ; C07K14/435 ; C07K16/00
Abstract:
The present invention relates to a peptide comprising an epitope within the macrophage scavenger receptor B-I, a method of using the same, a nucleic acid encoding the same and an antibody that binds to the epitope.
Public/Granted literature
- US20170304436A1 NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION Public/Granted day:2017-10-26
Information query
